ATLANTA, GA – – (ACCESSWIRE – November 16, 2022) – – Holzer & Holzer, LLC is investigating whether Twist Bioscience Corporation (“Twist Bioscience” or the “Company”) (NASDAQ: TWST) complied with federal securities laws. On November 15, 2022, Scorpion Capital published a report alleging Twist Bioscience is an “unsustainable Ponzi-like scheme based on price dumping and customer subsidies to buy revenue and create the illusion of ‘growth.’” Following this report, the Company’s stock price dropped.
If you purchased Twist Bioscience stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at firstname.lastname@example.org or Joshua Karr, Esq. at email@example.com, call our toll-free number at (888) 508-6832, or visit our website at https://holzerlaw.com/case/twist-bioscience/ to discuss your legal rights.